Enhanced intracellular translocation and biodistribution of gold nanoparticles functionalized with a cell-penetrating peptide (VG-21) from vesicular stomatitis virus

Biomaterials

Volumn 35, Issue 35, 2014, Pages 9484-9494

  Tiwari, Pooja Munnilal ^a   Eroglu, Erdal ^a,b   Bawage, Swapnil Subhash ^a   Vig, Komal ^a   Miller, Michael E ^c   Pillai, Shreekumar ^a   Dennis, Vida A ^a   Singh, Shree Ram ^a  

^a ALABAMA STATE UNIVERSITY   (United States)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c AUBURN UNIVERSITY   (United States)

Author keywords

Cell penetrating peptide; Drug delivery; Functionalized gold nanoparticles; Vesicular stomatitis virus

Indexed keywords

CELL CULTURE; CYTOLOGY; DRUG DELIVERY; ELECTROMAGNETIC INDUCTION; ELECTRON MICROSCOPY; EMISSION SPECTROSCOPY; FIBER OPTIC SENSORS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; GENES; GOLD; LIGHT SCATTERING; MAMMALS; MEDICAL APPLICATIONS; METAL NANOPARTICLES; MOBILE SECURITY; NANOPARTICLES; OPTICAL EMISSION SPECTROSCOPY; PEPTIDES; TISSUE; TISSUE ENGINEERING; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY; VIRUSES;

CELL PENETRATING PEPTIDES (CPPS); CELL-PENETRATING PEPTIDE; CELLULAR INTERNALIZATION; FUNCTIONALIZED GOLD NANOPARTICLES; GOLD NANOPARTICLES (GNPS); HISTOPATHOLOGICAL ANALYSIS; INTRACELLULAR TRANSLOCATION; VESICULAR STOMATITIS VIRUS;

CELLS;

CELL PENETRATING PEPTIDE; CYTOKINE; DRUG VEHICLE; GOLD NANOPARTICLE; INTERLEUKIN 6; NANOCONJUGATE; NANOPARTICLE; PROTEIN VG 21; PROTEIN VG 21 GOLD NANOPARTICLE CONJUGATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; G PROTEIN, VESICULAR STOMATITIS VIRUS; GOLD; MEMBRANE PROTEIN; METAL NANOPARTICLE; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; COS 7 CELL LINE; CYTOKINE PRODUCTION; DRUG ACCUMULATION; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFECT; DRUG TRANSPORT; ENDOSOME; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HELA CELL LINE; HEP 2 CELL LINE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INDUCTIVELY COUPLED PLASMON OPTICAL EMISSION SPECTROSCOPY; INFRARED SPECTROSCOPY; INTERNALIZATION; LIGHT SCATTERING; LIVER; MACROPHAGE; MASS SPECTROMETRY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SPLEEN; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; VERO CELL LINE; VESICULOVIRUS; ZETA POTENTIAL; ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; DRUG EFFECTS; FEMALE; METABOLISM;

EUKARYOTA; MUS; VESICULAR STOMATITIS VIRUS;

ANIMALS; CELL SURVIVAL; CELL-PENETRATING PEPTIDES; CERCOPITHECUS AETHIOPS; COS CELLS; FEMALE; GOLD; HELA CELLS; HUMANS; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; METAL NANOPARTICLES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; TISSUE DISTRIBUTION; TUMOR NECROSIS FACTOR-ALPHA; VERO CELLS; VESICULOVIRUS; VIRAL ENVELOPE PROTEINS;

EID: 84920396574     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.07.032     Document Type: Article

References (52)

1. Giljohann D.A., Seferos D.S., Daniel W.L., Massich M.D., Patel P.C., Mirkin C.A. Gold nanoparticles for biology and medicine. Angew Chem Int Ed 2010, 49:3280-3294.
2. Tiwari P., Vig K., Dennis V., Singh S. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 2011, 1:31-63.
3. Nelson C.E., Kintzing J.R., Hanna A., Shannon J.M., Gupta M.K., Duvall C.L. Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity invivo. ACS Nano 2013, 7:8870-8880.
4. Hou K.K., Pan H., Ratner L., Schlesinger P.H., Wickline S.A. Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides. ACS Nano 2013, 7:8605-8615.
5. Jin E., Zhang B., Sun X., Zhou Z., Ma X., Sun Q., et al. Acid-active cell-penetrating peptides for invivo tumor-targeted drug delivery. JAm Chem Soc 2012, 135:933-940.
6. de la Fuente J.M., Berry C.C. Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. Bioconjug Chem 2005, 16:1176-1180.
7. Chanda N., Kattumuri V., Shukla R., Zambre A., Katti K., Upendran A., et al. Bombesin functionalized gold nanoparticles show invitro and invivo cancer receptor specificity. Proc Natl Acad Sci 2010, 107(19):8760-8765. 10.1073/pnas.1002143107.
8. Bartczak D., Muskens O.L., Sanchez-Elsner T., Kanaras A.G., Millar T.M. Manipulation of invitro angiogenesis using peptide-coated gold nanoparticles. ACS Nano 2013, 7:5628-5636.
9. Oyelere A.K., Chen P.C., Huang X., El-Sayed I.H., El-Sayed M.A. Peptide-conjugated gold nanorods for nuclear targeting. Bioconjug Chem 2007, 18:1490-1497.
10. Wang C., Wang J., Liu D., Wang Z. Gold nanoparticle-based colorimetric sensor for studying the interactions of beta-amyloid peptide with metallic ions. Talanta 2010, 80:1626-1631.
11. Hoyer J., Neundorf I. Peptide vectors for the nonviral delivery of nucleic acids. Acc Chem Res 2012, 45:1048-1056.
12. Deshayes S., Morris M.C., Divita G., Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci 2005, 62:1839-1849.
13. Hao X., Wu J., Shan Y., Cai M., Shang X., Jiang J., et al. Caveolae-mediated endocytosis of biocompatible gold nanoparticles in living Hela cells. JPhys Condens Matter 2012, 24(16):164207. http://dx.doi.org/10.1088/0953%208984/24/16/164207.
14. Trabulo S., Cardoso A.L., Mano M., De Lima M.C.P. Cell-penetrating peptides-mechanisms of cellular uptake and generation of delivery systems. Pharmaceuticals 2010, 3:961-993.
15. Frankel A.D., Pabo C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
16. Karagiannis E.D., Urbanska A.M., Sahay G., Pelet J.M., Jhunjhunwala S., Langer R., et al. Rational design of a biomimetic cell penetrating peptide library. ACS Nano 2013, 7:8616-8626.
17. Crombez L., Aldrian-Herrada G., Konate K., Nguyen Q.N., McMaster G.K., Brasseur R., et al. Anew potent secondary amphipathic cell-penetrating peptide for siRNA delivery into mammalian cells. Mol Ther 2009, 17:95-103.
18. Tran N.T.T., Wang T.-H., Lin C.-Y., Tsai Y.-C., Lai C.-H., Tai Y., et al. Direct synthesis of rev peptide-conjugated gold nanoparticles and their application in cancer therapeutics. Bioconjug Chem 2011, 22:1394-1401.
19. Sun L., Liu D., Wang Z. Functional gold nanoparticle-peptide complexes as cell-targeting agents. Langmuir 2008, 24:10293-10297.
20. Scarì G., Porta F., Fascio U., Avvakumova S., Dal Santo V., De Simone M., et al. Gold nanoparticles capped by a GC-containing peptide functionalized with an RGD motif for integrin targeting. Bioconjug Chem 2012, 23:340-349.
21. Nakase I., Hirose H., Tanaka G., Tadokoro A., Kobayashi S., Takeuchi T., et al. Cell-surface accumulation of flock house virus-derived peptide leads to efficient internalization via macropinocytosis. Mol Ther 2009, 17:1868-1876.
22. Tkachenko A.G., Xie H., Liu Y., Coleman D., Ryan J., Glomm W.R., et al. Cellular trajectories of peptide-modified gold particle complexes: comparison of nuclear localization signals and peptide transduction domains. Bioconjug Chem 2004, 15:482-490.
23. Hastie E., Grdzelishvili V.Z. Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer. JGen Virol 2012, 93:2529-2545.
24. Stojdl D.F., Lichty B., Knowles S., Marius R., Atkins H., Sonenberg N., et al. Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 2000, 6:821-825.
25. Ammayappan A., Peng K.W., Russell S.J. Characteristics of oncolytic vesicular stomatitis virus displaying tumor targeting ligands. JVirol 2013, 24:13543-13555.
26. Özduman K., Wollmann G., Piepmeier J.M., van den Pol A.N. Systemic vesicular stomatitis virus selectively destroys multifocal glioma and metastatic carcinoma in brain. JNeurosci 2008, 28:1882-1893.
27. Roche S., Albertini A.A., Lepault J., Bressanelli S., Gaudin Y. Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited. Cell Mol Life Sci 2008, 65:1716-1728.
28. Mironov A.A., Beznoussenko G.V., Nicoziani P., Martella O., Trucco A., Kweon H.S., et al. Small cargo proteins and large aggregates can traverse the Golgi by a common mechanism without leaving the lumen of cisternae. JCell Biol 2001, 155:1225-1238.
29. Hirano M., Kato S., Kobayashi K., Okada T., Yaginuma H., Kobayashi K. Highly efficient retrograde gene transfer into motor neurons by a lentiviral vector pseudotyped with fusion glycoprotein. PLoS One 2013, 8:e75896. 10.1371/journal.pone.0075896.
30. Farley D.C., Iqball S., Smith J.C., Miskin J.E., Kingsman S.M., Mitrophanous K.A. Factors that influence VSV-G pseudotyping and transduction efficiency of lentiviral vectors-invitro and invivo implications. JGene Med 2007, 9:345-356.
31. Lo H.L., Yee J.K. Production of vesicular stomatitis virus G glycoprotein (VSV-G) pseudotyped retroviral vectors. Curr Protoc Hum Genet 2007, 12. 10.1002/0471142905.hg1207s52.
32. DePolo N.J., Reed J.D., Sheridan P.L., Townsend K., Sauter S.L., Jolly D.J., et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2000, 2:218-222.
33. Gautam A., Chaudhary K., Kumar R., Sharma A., Kapoor P., Tyagi A., et al. In silico approaches for designing highly effective cell penetrating peptides. JTransl Med 2013, 11(1):74. http://dx.doi.org/10.1186/1479-5876-11-74.
34. Kaur H., Garg A., Raghava G.P. PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein Pept Lett 2007, 14:626-631.
35. Willard L., Ranjan A., Zhang H., Monzavi H., Boyko R.F., Sykes B.D., et al. VADAR: a web server for quantitative evaluation of protein structure quality. Nucleic Acids Res 2003, 31:3316-3319.
36. Gasteiger E., Hoogland C., Gattiker A., Se Duvaud, Wilkins M., Appel R., et al. Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook 2005, 571-607. Humana Press. J. Walker (Ed.).
37. Chithrani B.D., Ghazani A.A., Chan W.C.W. Determining the size and shape Dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6:662-668.
38. Si S., Mandal T.K. pH-controlled reversible assembly of peptide-functionalized gold nanoparticles. Langmuir 2006, 23:190-195.
39. Albanese A., Chan W.C.W. Effect of gold nanoparticle aggregation on cell uptake and toxicity. ACS Nano 2011, 5:5478-5489.
40. Bastus N.G., Sanchez-Tillo E., Pujals S., Farrera C., Kogan M.J., Giralt E., et al. Peptides conjugated to gold nanoparticles induce macrophage activation. Mol Immunol 2009, 46:743-748.
41. Abdelhalim M.A., Jarrar B.M. Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration. JNanobiotechnol 2012, 10(5). http://dx.doi.org/10.1186/1477-3155-10-5.
42. Mao Z., Wang B., Ma L., Gao C., Shen J. The influence of polycaprolactone coating on the internalization and cytotoxicity of gold nanoparticles. Nanomed Nanotechnol Biol Med 2007, 3:215-223.
43. Guterstam P., Madani F., Hirose H., Takeuchi T., Futaki S., El Andaloussi S., et al. Elucidating cell-penetrating peptide mechanisms of action for membrane interaction, cellular uptake, and translocation utilizing the hydrophobic counter-anion pyrenebutyrate. Biochim Biophys Acta 2009, 12:2509-2517.
44. Freese C., Gibson M.I., Klok H.-A., Unger R.E., Kirkpatrick C.J. Size- and coating-dependent uptake of polymer-coated gold nanoparticles in primary human dermal microvascular endothelial cells. Biomacromolecules 2012, 13:1533-1543.
45. Cho E.C., Au L., Zhang Q., Xia Y. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small 2010, 6:517-522.
46. Krpetić Ze, Porta F., Caneva E., Dal Santo V., Scariỳ G. Phagocytosis of biocompatible gold nanoparticles. Langmuir 2010, 26:14799-14805.
47. Bhattacharya R., Patra C.R., Earl A., Wang S., Katarya A., Lu L., et al. Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells. Nanomed Nanotechnol Biol Med 2007, 3:224-238.
48. Balasubramanian S.K., Jittiwat J., Manikandan J., Ong C.N., Yu L.E., Ong W.Y. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats. Biomaterials 2010, 31:2034-2042.
49. Cho W.S., Kim S., Han B.S., Son W.C., Jeong J. Comparison of gene expression profiles in mice liver following intravenous injection of 4 and 100 nm-sized PEG-coated gold nanoparticles. Toxicol Lett 2009, 191:96-102.
50. Kim E.Y., Schulz R., Swantek P., Kunstman K., Malim M.H., Wolinsky S.M. Gold nanoparticle-mediated gene delivery induces widespread changes in the expression of innate immunity genes. Gene Ther 2012, 19:347-353.
51. Massich M.D., Giljohann D.A., Seferos D.S., Ludlow L.E., Horvath C.M., Mirkin C.A. Regulating immune response using polyvalent nucleic acid-gold nanoparticle conjugates. Mol Pharm 2009, 6:1934-1940.
52. Niikura K., Matsunaga T., Suzuki T., Kobayashi S., Yamaguchi H., Orba Y., et al. Gold nanoparticles as a vaccine platform: influence of size and shape on immunological responses invitro and invivo. ACS Nano 2013, 7:3926-3938.